medigraphic.com
ISSN 1561-3046 (Electronic)

2016, Number 3

<< Back Next >>

Rev Cub Med Mil 2016; 45 (3)

Survival of the cirrhotic patient with hypertensive portal gastropathy

Pérez LM, Infante VM, Guerrero GY, Román MY, Ávalos RM, Rodríguez ÁD

Language: Spanish
References: 23
Page: 291-299
PDF size: 153.50 Kb.


ABSTRACT

Introduction: Hypertensive portal gastropathy is a complication of portal hypertension that occurs in cirrhotic patients.
Objective: Determine the probability of survival in a group of cirrhotic patients with hypertensive portal gastropathy.
Methods: a longitudinal, prospective follow-up was conducted to study the survival of thirty four (34) patients with liver cirrhosis and they were treated at the Gastroenterology Service of Dr. Luis Díaz Soto Central Military Hospital from October 2012 to October 2015. Full-length and strata survival curves were constructed, according to Child-Pugh-Turcotte classification, as well as etiology of cirrhosis, severity of gastropathy, and occurrence of acute bleeding during the observation period. Kaplan-Meier method was used and the comparison of the curves by the logarithm of ranges.
Results: A global survival probability of 94.1 % was observed at two months and 61.7 % at 30 months. The mean survival for patients with mild and severe gastropathy was 29.1 and 29.7 months, respectively; this was 28.3 months for cases with C virus cirrhosis and 30.1 months for those of other etiologies. There were predominant cases in Child A (41.2 %) and B (47.1 %), with an average survival of 33.5 and 30.1 months; For Child C (12 %) was 12 months; (P = 0.05). 35.3 % of the cases bled, with an average survival of 25.5 months lower than those who did not bleed (p = 0.35).
Conclusions: The presence of hypertensive portal gastropathy is associated with a greater probability of dying when there is a greater deterioration of the liver function or acute bleeding has occurred, as of 30 months after having been diagnosed.


REFERENCES

  1. Iwao T, Toyonaga A, Sumino M, Takagi K, Oho K, Nishizono M, et al. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology. 1992;102(6):2060-5.

  2. de Macedo GF, Ferreira FG, Ribeiro MA, Szutan LA, Assef MS, Rossini LG. Reliability in endoscopic diagnosis of portal hypertensive gastropathy. World J Gastrointest Endosc [Internet]. 2013 Jul 16 [cited 2015 Jun 16];5(7):323-31. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711063

  3. Thuluvath PJ, Yoo HY. Portal Hypertensive gastropathy. Am J Gastroenterol. 2002;97(12):2973-8.

  4. Curvelo LA, Brabosa W, Rhor R, Lanzoni V, Parise ER, Ferrari AP, et al. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach. J Gastroenterol Hepatol [Internet]. 2009 Sep [cited 2015 Dec 23]; 24(9):1541-6. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1746.2009.05871.x/full

  5. Biecker E. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol [Internet]. 2013 [cited 2015 Apr 12];19:5035-50. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746375/

  6. Iber FL. Portal hypertensive gastropathy. Am J Gastroenterol. 1993;88(11):1812-3.

  7. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. Journal Hepatol [Internet]. 2000 [citado 2015 Jul 29];33(5):846-52. Available from: http://www.journal-of-hepatology.eu/article/S0168-8278(00)80320-7/fulltext

  8. Child CG, editor. The liver and portal hypertension. Philadelphia: W B Saunders Co; 1964.

  9. Asociación Médica Mundial (AMM). Declaración de Helsinki: Principios éticos para las investigaciones médicas en seres humanos; c>2016 http://www.wma.net/es/30publications/10policies/b3/index.html

  10. Rodríguez Hernández H, Jacobo Karam JS, Castańón Santillán MC, Arámbula Chávez M, Martínez Aguilar G. Supervivencia de pacientes concirrosis hepática en el Hospital General Regional del IMSS, Durango. Gac Méd Méx [Internet]. 2002 [citado 2013 Nov 12]; 138(4):225-30. Disponible en: http://www.medigraphic.com/pdfs/gaceta/gm-2002/gm024d.pdf

  11. Kim MY, Choi H, Baik SK, Yea CJ, Won CS, Byun JW, et al. Portal hypertensive gastropathy: correlation with portal hypertension and prognosis in cirrhosis. Dig Dis Sci [Internet]. 2010 Dec [citado 2015 Jul 15];55(12):3561-7. Disponible en: http://link.springer.com/article/10.1007/s10620-010-1221-6/fulltext.html

  12. Pińero R, Olavarria R, Urquiola G, Yaraure M, Ramon Poleo J. Gastropatia portal hipertensiva: correlacion endoscopico histologica. G E N. 1994;48(1):7-9.

  13. McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, et al. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut. 1985;26(11):1226-32.

  14. Hou MC, Lin HC, Chen CH, Kuo BI, Perng CL, Lee FY, et al. Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation. Gastrointest Endosc. 1995;42(2):139-44.

  15. Gostout CJ, Viggiano TR, Balm RK. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol. 1993;88(12):2030-3.

  16. Zullo A, Hassan C, Ridola L, Francesco VD. Helicobacter pylori and portal hypertensive gastropathy: any new information? Ann Gastroenterol [Internet]. 2014 [citado 2015 Apr 12];27(1):91. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24714507/

  17. Abbas Z, Yakoob J, Usman MW, Shakir T, Hamid S, Jafri W. Effect of Helicobacter pylori and its Virulence Factors on Portal Hypertensive Gastropathy and Interleukin (IL)-8, IL-10, and Tumor Necrosis Factor-alpha Levels. Saudi J Gastroenterol [Internet]. 2014 Mar-Apr [citado 2015 Jan 29];20(2):120-7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987152/

  18. Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology [Internet]. 2000 Jul [citado 2015 Apr 12];119(1):181-7. Available from: http://dx.doi.org/10.1053/gast.2000.8555

  19. Perini RF, Camara PR, Ferraz JG. Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice. Nature clinical practice Gastroenterology & hepatology [Internet]. 2009 Mar [citado 2015 Mar 11];6(3):150-8. Available from: http://www.nature.com/nrgastro/journal/v6/n3/full/ncpgasthep1356.html

  20. Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology. 2000;119(1):181-7.

  21. Albillos Martinez A. Supervivencia de pacientes con cirrosis tras la primera hemorragia aguda por varices esofágicas. Rev Esp Enferm Dig [Internet]. 2009 Apr [citado 2015 Ene 21];101(4):231-5. Available from: http://scielo.isciii.es/scielo.php?pid=S1130-01082009000400001&script=sci_arttext&tlng=e

  22. Abbasi A, Bhutto AR, Butt N, Munir SM, Dhillo AK. Frequency of portal hypertensive gastropathy and its relationship with biochemical, haematological and endoscopic features in cirrhosis. J Coll Physicians Surg Pak [Internet]. 2011 Dec [citado 2015 Nov 26];21(12):723-6. Available from: http://www.jcpsp.pk/archive/2011/Dec2011/02.pdf

  23. Kumar A, Mishra SR, Sharma P, Sharma BC, Sarin SK. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics. J Clin Gastroenterol. 2010;44(4):294-300.




2020     |     www.medigraphic.com